MedPath

A Comparative Effectiveness RCT of Optimized Cessation Treatments

Phase 4
Completed
Conditions
Smoking Cessation
Interventions
Drug: Preparation Nicotine Mini-Lozenges
Behavioral: in-person counseling and quitline counseling
Drug: Combination NRT (nicotine patch + nicotine mini-lozenges)
Behavioral: Intensive In-Person Cessation Counseling
Behavioral: Extended Maintenance Counseling Calls
Behavioral: Automated Adherence Calls
Registration Number
NCT02301403
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

This study is a 2-arm randomized clinical trial (RCT). Participants motivated to quit smoking will be randomized to one of two treatments: 1) a Modern Usual Care (M-UC) vs. 2) Abstinence-Optimized Cessation Treatment (AOCT). The components for the optimized treatment have strong theoretical and empirical support from the investigators previous screening studies.

Detailed Description

The ultimate goal of this research is to develop a chronic care treatment package for smokers that will address the challenges and opportunities of each phase of the cessation process - motivation, preparation, cessation, maintenance, and relapse recovery. That is, to develop treatments for smokers not yet ready to quit, those who are preparing to quit, those actively engaged in the quitting process and those who have tried to quit but relapsed. To achieve this goal, this research comprises three distinct research studies, each of which represent a phase in a comprehensive chronic care treatment model for clinical intervention with smokers in the primary care setting: the Motivation Study, the Cessation Study, and the Long-term Quitting Study. The goal of each study is to test and identify effective intervention components for distinct phases of the smoking cessation process. These components will then be combined for future research on the effectiveness of this chronic care treatment package

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
623
Inclusion Criteria
  • age >=18 years
  • smoking >4 cigarettes/day for the previous 6 months
  • able to read, write, and speak English
  • have reliable phone access and agree to respond to Interactive Voice Response (IVR) phone prompts
  • and if currently using NRT, agreeing to use only study medication for the duration of the study
  • we will not exclude participants based on their prior use of cessation medication or if they use multiple tobacco products in order to enhance real-world generalization (these will be statistically controlled in analyses)
  • not currently attempting to quit smoking
  • not intending to quit smoking (defined as no plans to quit in the next month)
  • and planning to remain in the intervention catchment area for at least 12 months.
Exclusion Criteria
  • currently taking bupropion or varenicline
  • medical contraindications to using NRT including hospitalized (for at least one night) for a stroke, heart attack, congestive heart failure or diabetes in the last 30 days
  • diagnosis of or treatment for schizophrenia, a psychotic disorder or bipolar disorder in the last 10 years
  • and, if the participant is a woman of childbearing potential, being pregnant or intending to becoming pregnant or unwillingness to use an approved method of birth control during treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Abstinence-Optimized Cessation TreatmentIntensive In-Person Cessation CounselingThere are 5 intervention components to include in the AOCT package: 1) Preparation Nicotine Mini-Lozenges; 2) 26-week postquit Combination NRT (nicotine patch + nicotine mini-lozenges); 3) Intensive In-Person Cessation Counseling; 4) Extended Maintenance Counseling Calls; and 5) Automated Adherence Calls.
Modern Usual CareNicotine patchParticipants assigned to the M-UC will receive 8 weeks of nicotine patch, a single brief, in-person counseling session, a faxed referral to the Wisconsin Tobacco Quit Line (WTQL), and will be signed up for either the QUITNOW app or the Web Coach (both provided by Alere Wellbeing, the vendor that provides the WTQL services).
Modern Usual Carein-person counseling and quitline counselingParticipants assigned to the M-UC will receive 8 weeks of nicotine patch, a single brief, in-person counseling session, a faxed referral to the Wisconsin Tobacco Quit Line (WTQL), and will be signed up for either the QUITNOW app or the Web Coach (both provided by Alere Wellbeing, the vendor that provides the WTQL services).
Abstinence-Optimized Cessation TreatmentExtended Maintenance Counseling CallsThere are 5 intervention components to include in the AOCT package: 1) Preparation Nicotine Mini-Lozenges; 2) 26-week postquit Combination NRT (nicotine patch + nicotine mini-lozenges); 3) Intensive In-Person Cessation Counseling; 4) Extended Maintenance Counseling Calls; and 5) Automated Adherence Calls.
Abstinence-Optimized Cessation TreatmentPreparation Nicotine Mini-LozengesThere are 5 intervention components to include in the AOCT package: 1) Preparation Nicotine Mini-Lozenges; 2) 26-week postquit Combination NRT (nicotine patch + nicotine mini-lozenges); 3) Intensive In-Person Cessation Counseling; 4) Extended Maintenance Counseling Calls; and 5) Automated Adherence Calls.
Abstinence-Optimized Cessation TreatmentCombination NRT (nicotine patch + nicotine mini-lozenges)There are 5 intervention components to include in the AOCT package: 1) Preparation Nicotine Mini-Lozenges; 2) 26-week postquit Combination NRT (nicotine patch + nicotine mini-lozenges); 3) Intensive In-Person Cessation Counseling; 4) Extended Maintenance Counseling Calls; and 5) Automated Adherence Calls.
Abstinence-Optimized Cessation TreatmentAutomated Adherence CallsThere are 5 intervention components to include in the AOCT package: 1) Preparation Nicotine Mini-Lozenges; 2) 26-week postquit Combination NRT (nicotine patch + nicotine mini-lozenges); 3) Intensive In-Person Cessation Counseling; 4) Extended Maintenance Counseling Calls; and 5) Automated Adherence Calls.
Primary Outcome Measures
NameTimeMethod
Number of Participants With Abstinence From Smoking6 months post treatment

The outcome measure consists of the number of participants reporting abstinence from smoking at 6 months that is biochemically confirmed (exhaled carbon monoxide \< 6 parts per million).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath